The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Parsey Merdad since 2020.
This trader's CIK number is 1792150.
At the time of last reporting, Parsey Merdad was the Chief Medical Officer of Gilead Sciences, Inc.. (stock ticker symbol GILD).
Also see all insider trading activities at Gilead Sciences, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | GILD | 0 | $0 | 227,277 | $20,420,303 | 217,275 | $11,860,711 |
| 2023 | GILD | 0 | $0 | 22,649 | $1,799,062 | 17,012 | $0 |
| 2022 | GILD | 0 | $0 | 0 | $0 | 15,828 | $0 |
| 2021 | GILD | 0 | $0 | 0 | $0 | 8,555 | $0 |
| 2020 | GILD | 0 | $0 | 182 | $12,434 | 5,101 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-12-10 | GILD | Option Ex | 3,820 | .00 | 0 |
| 2024-11-27 | GILD | Option Ex | 145,413 | 61.65 | 8,964,711 |
| 2024-11-27 | GILD | Sale | 164,211 | 91.88 | 15,087,706 |
| 2024-11-06 | GILD | Option Ex | 25,000 | 57.92 | 1,448,000 |
| 2024-11-06 | GILD | Sale | 25,590 | 91.50 | 2,341,485 |
| 2024-10-01 | GILD | Sale | 2,000 | 83.83 | 167,660 |
| 2024-09-12 | GILD | Option Ex | 25,000 | 57.92 | 1,448,000 |
| 2024-09-12 | GILD | Sale | 21,246 | 84.50 | 1,795,287 |
| 2024-09-10 | GILD | Option Ex | 3,821 | .00 | 0 |
| 2024-07-01 | GILD | Sale | 2,000 | 68.63 | 137,260 |
| 2024-06-10 | GILD | Option Ex | 3,820 | .00 | 0 |
| 2024-04-01 | GILD | Sale | 2,000 | 72.96 | 145,920 |
| 2024-03-10 | GILD | Option Ex | 10,401 | .00 | 0 |
| 2024-02-28 | GILD | Sale | 2,000 | 73.18 | 146,360 |
| 2024-02-29 | GILD | Sale | 8,230 | 72.74 | 598,625 |
| 2023-12-10 | GILD | Option Ex | 2,779 | .00 | 0 |
| 2023-09-12 | GILD | Sale | 1,501 | 76.99 | 115,561 |
| 2023-09-10 | GILD | Option Ex | 2,779 | .00 | 0 |
| 2023-06-13 | GILD | Sale | 1,485 | 76.90 | 114,196 |
| 2023-03-13 | GILD | Sale | 6,126 | 78.99 | 483,892 |
| 2023-03-10 | GILD | Option Ex | 11,454 | .00 | 0 |
| 2023-03-01 | GILD | Sale | 12,984 | 79.96 | 1,038,226 |
| 2022-12-30 | GILD | Sale | 553 | 85.33 | 47,187 |
| 2022-12-10 | GILD | Option Ex | 1,039 | .00 | 0 |
| 2022-11-10 | GILD | Option Ex | 5,099 | .00 | 0 |
| 2022-09-10 | GILD | Option Ex | 1,039 | .00 | 0 |
| 2022-06-10 | GILD | Option Ex | 1,039 | .00 | 0 |
| 2022-03-10 | GILD | Option Ex | 7,612 | .00 | 0 |
| 2021-11-10 | GILD | Option Ex | 5,100 | .00 | 0 |
| 2021-03-10 | GILD | Option Ex | 3,455 | .00 | 0 |
| 2020-11-10 | GILD | Option Ex | 5,101 | .00 | 0 |
| 2020-08-17 | GILD | Sale | 182 | 68.32 | 12,434 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Parsey Merdad (Chief Medical Officer of Gilead Sciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.